Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that…
Category: Insights
Rising Hypertension Rates Boost Blood Pressure Cuffs Market Revenue, Projected to Reach USD 1.0 Billion by 2031 at 6.5% CAGR: Transparency Market Research, Inc.
The global blood pressure cuffs market is projected to rise at a CAGR of 6.5% from 2023 to 2031. As…
Global Pharmaceutical Packaging Market Demand to Reach US$ 216.2 Million by 2034, Advancing at a 7.10 % CAGR
The pharmaceutical packaging market is estimated to be worth US$ 108.9 billion in 2024 and is projected to be valued…
Biopharmaceutical Manufacturing Capacity and Production, 21st Annual Report and Survey: A Study of Biotherapeutic Developers and Contract Manufacturing Organizations
This report includes data-rich analysis to help improve your decision making in biomanufacturing. In-depth analysis of…
Onconic Therapeutics gibt positive Phase-3-Ergebnisse für JAQBO auf der Digestive Diseases Week 2024 bekannt
Onconic Therapeutics, ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich der Entwicklung innovativer Behandlungen für Onkologie…
ConcertAI: ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment with oliparib monotherapy may improve duration of therapy and overall survival
ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for…
Las Vegas Sands Continues Capacity-Building Investments for the Asian Community Development Council with a $225,000 Donation
Las Vegas Sands (NYSE: LVS) has contributed $225,000 through Sands Cares to the Asian Community Development Council (ACDC) for three…
Mindy B. Young Joins Huntsman Mental Health Foundation as Assistant Vice President of Giving
Huntsman Mental Health Foundation (HMHF) is pleased to announce the appointment of Mindy B. Young as Assistant Vice…
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased…
NCCN 2024 Annual Conference Shares Cancer Care Updates for Practical, Immediate Use in Practice
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals during…